For centuries, the rapid spread and cure of infectious diseases have been a major concern to the progress and survival of humans. These diseases are the global burden and the prominent cause for the worldwide deaths and disability. Nanomedicine has emerged as the most excellent tool to eradicate and halt their spread. Various nanoformulations (NFs) using advanced nanotechnology are in demand. Recently, hydrogel and nanogel based drug delivery devices poses new prospects to simulate the natural intelligence of various biological systems. Owing to their unique porous interpenetrating network design, hydrophobic drug incorporation and stimulus sensitivity hydrogels owe excellent potential as targeted drug delivery system. Present review is an attempt to highlight the recent trends of hydrogel based drug delivery systems for the delivery of therapeutic agents and diagnostics for the major infectious diseases including Acquired immune deficiency syndrome (AIDS), Malaria, Tuberculosis, Influenza and Ebola. Future prospective and challenges are also briefed.
Introduction
From last few centuries, humans are handicapped to the sudden epidemics and emerging infectious diseases that makes them curious to seek growth in the development of new vaccines, antimicrobials and thus presently devoted towards nanomedicine and nanotechnology based therapeutics. Emerging infections (EIs) are basically defined as the infections arousing in a population, which existed previously and is continuously spreading in that geographic range.
1, 2 Infectious diseases are considered as the third leading cause of deaths in US. 3, 4 In early 1980's human immunodeficiency virus (HIV) was initially accepted and had infected an estimated of 3 million people world-wide (UNAIDS Epidemic update, 2008) leading to AIDS. Despite the new advancements in the field of anti-infectious agents in recent years, the treatment for the variety of bacterial and fungal infections as well as parasitic and viral diseases upholds a great challenge.
To have a basic understanding of the infectious diseases it can be described as a disorder occurring from the presence of pathogenic agent, which includes virus, bacterium, fungus. The infectious diseases come in the category of communicable diseases as they can be transferred from one person to the other that include dengue, malaria and tuberculosis whereas when the transfer occurs from one species to other, flu or influenza occurs. 5 These disease can be broadly classified firstly as diseases, which firmly persist like malaria, tuberculosis secondly earlier unknown diseases like severe acute respiratory syndrome and lastly to the diseases, which threaten to enhance in the near future (e.g., avian influenza). The developing countries are the major sufferers and half of the deaths are happening due to these infectious diseases. 6 For a better understanding, we need to gather our knowledge about the bacterial pathogens, which are classified as extracellular and intracellular pathogens on the basis of the in vivo life and pathogenicity. The main target in the localized diseases such as inflammation and infection are the overexpressed epitopes or receptors. The initialization of the use of antibiotics with the penicillin in late 1940s was a great success and further advancements for the stronger antibiotics begun. 7 Though the resistance to the antimicrobial drugs was a threat to the hospitals and community and the number of effective drugs to control infection by the old bacteria decreased. 8, 9 Thus the invention of the nano carrier systems offered antibiotics to be delivered selectively to phagocytic cells and to increase their cellular penetration and the treatment of the intracellular infections. 10 The factors behind these infections include number of aspects owing to the change in the environment, which increases the frequency of the contact with the host carrying an infection and thus increase the chance of encountering the microorganisms formerly unfamiliar to beings.
Tuberculosis (TB) is one of the most feared diseases until the discovery of antibiotics in 1940s that caused large scale human deaths. 11, 12 Over the last 20 years researchers are in the urge of discovering nanotechnology based drug carriers such as smart materials "nano/micro gels" inside which the cargos can be encapsulated and gives a sustained release of drugs rather than the conventional free drug delivery. 13 In the present article one of the section deals with the brief overview of the disease and the various benefits of hydrogel based drug delivery systems (DDS) for TB.
Nanomedicine actively target locations by the use of various NFs 14 as a DDS which include nanoparticles, 8 polymeric micelles, 15, 16 nanorods, 17, 18 nanospheres, 19, 20 solid lipid nanoparticles, 21, 22 nanolipososmes, 23, 24 dendrimers, 25, 26 metal nanoparticles 27, 28 , fullerenes and quantum dots. 29, 30 These NFs have been useful in the development of the various different routes like systemic, oral, pulmonary, transdermal and have been helpful for the drug targeting and On-demand drug delivery techniques. 31 The technologies of encapsulating various cargos inside these NFs have been the main attention owing to their numerous benefits like low toxicity, effective therapeutic dosages. Among all these nanoforms hydrogels especially nanogels have gained lot of attention and have emerged as an innovative and promising therapeutic interventions. [32] [33] [34] [35] Moreover the clinical applications of these NFs are being upgraded yet the implementations of few strategies require more advanced therapies. 36, 37 The present article focusses on hydrogel based drug delivery systems and clinical applications of these systems to treat major infectious diseases. The other infectious diseases, which have caused destruction to human health care world-wide include the AIDS, tuberculosis, malaria, Influenza A, Ebola that have been discussed in the present review.
Hydrogel based systems for HIV

HIV Pathogenesis
Briefly, HIV is known to be a retrovirus due to its reverse mechanism than that used by human cells. 38 The retrovirus stores the genetic information as RNA rather as DNA as seen commonly in other living things.
39
, 40 The HIV obliterate the CD+4 lymphocytes and the infected people become more prone to the other infectious organisms, which is the worst aftermath of the virus as it is known that the death of the person is generally due to the other infections rather than directly from HIV. 41, 42 In simpler terms, the mechanism can be understood in terms of the fact that as soon as the virus enters the body attachment of numerous white blood cells occurs. Most importantly the helper T lymphocytes activate and coordinate with the other activated cells of the immune system. The surface receptor CD4
helps the HIV to attach to T lymphocytes represented as CD4+. The occurrence of the errors i.e., the mutations by the enzyme the reverse transcriptase during the process of making a copy of RNA to DNA increases, which thereby increases the HIV and eventually enhances the replication process. In a very short interval of time, i.e., within few days the infected persons genital fluids as well as blood get infected simultaneously reducing the numbers of CD4+. The most initial step in the infection cycle of HIV is the union of viral cover with a target cell and followed by the release of its genome into cell. Studies also reveal that HIV enters into cell via endocytosis at the cell membrane. 43 
HIV Diagnosis
The awareness about the occurrence of HIV infection is still very low among rural populations. The efforts by the National disease control plans for effective and comprehensive health education campaigns to increase this awareness. 44 The 
Therapeutics for HIV
Till 1987 the invention of antiretroviral drugs and the treatment consisted of treating complications from opportunistic infections and malignancies. The first effective therapy against HIV was the nucleoside reverse transcriptase inhibitor (NRTI) zidovudine (AZT).
The invention of combinations of NRTIs was also not that successful to supress the virus for long periods. Thus highly active anti-retroviral therapy (HAART) was introduced instead of early anti-retroviral therapy (ART). Though it is a well-known fact that the NRTI are the major component of drug cocktails and are known to develop a varying degree of myopathy, lipodistrophy, or peripheral or central nervous system (CNS) neuropathy. These side effects are associated with mitochondrial toxicity of NRTIs. All these side effects are usually associated with mitochondrial toxicity of NRTIs that inhibit DNA polymerase γ and cause mtDNA dysfunction. 47 The reduction in the dosage and targeted drug delivery to the infected cells are the most demanding way to reduce the adverse toxic effects. Till date the clinical trials have shown no major success in anti-HIV based gels on conventional polymers or lipid emulsions, which suggest the need for novel molecular design of anti HIV gels. Supramolecular hydrogels are in high demand for the therapeutics. 69 In a recent report of conversion of anti-HIV prodrugs into self-delivery supramolecular hydrogelators show a great potential in sustained release of anti HIV therapeutics. 70 Li et al. The potential of cationic nanogel in HIV has been recently explored by many research groups. 72, 73 One of the important works led to the innovative development of biodegradable cationic cholesterol-ε-polylysine (CEPL) nanogel carriers for delivery of triphosphorylated NRTIs (nucleoside reverse transcriptase inhibitors). NRTIs are known to be the first-line drugs in AIDS treatment and components of the multi-drug cocktails of the HAART. The study presented a platform for low neurotoxicity and high anti-HIV activity eliminating many side effects for systemic administrations. This study demonstrated the advantages of a nanogel based delivery systems owing to small d~ 20nm nanocarriers prepared by the selfassembling spherical cationic CEPL polymer network. 43 Other functional modification by which nanogels are being modified for brain delivery is PEGylation of the cationic nanocarriers. 74 These smart carriers showed great potential to pass through the BBB.
PEGylated cationic nanocarriers, loaded with negatively charged drugs, demonstrated longer blood circulation and better chances to penetrate the BBB. It is well reported that the use of NRTIs in antiviral therapy is neurotoxic and it is very difficult to eradicate neuro AIDS by using it. A very innovative and novel study by
Greson et al. 73 demonstrated the use of nanogels based formulation as safer alternative to the current antiviral therapy. A low neurotoxicity and excellent antiviral activity of nano-NRTIs was reported ( Figure. 3). The nanogels was synthesized using PEG and PEI using crosslinkers. 76 The synthesized nanogels were then modified with MAL-PEG-NHS (M.w.
5,000, 33% wt) linker molecules. Nanogel NG2 was synthesized using carbodiimide- The special attention to the treatment and control of HIV inside the central nervous system is due to the fact that the anti HIV drugs have a major limitation associated with them that they do not cross the Blood brain barriers and their movement is restricted by the powerful enzymes and numerous transporters and including members of the ATP binding cassette (ABC) and solute carrier (SLC) superfamilies which makes the brain a viral reservation site and results in the viral resistance and also lead to HIV associated dementia.
Hydrogel based systems for Malaria
Malaria Pathogenesis
Malaria is the most known fatal disease with very common occurrence in Africa, affects almost 100 countries worldwide and has become a high concern for public health. The infection is transmitted by the bite of female Anopheles mosquito. 78 The main reason for malaria proliferation is the increased number of drug resistant parasites. The WHO report (2014) estimates 3.3 billion people are at risk of malaria, among 1.2 billion are at high risk. In high-risk areas, more than one malaria case occurs per 1000 population. 79 Briefly, the pathogenesis of malaria can be best understood by the understanding the mechanisms including parasite invasion, parasite biology, and host defence. 80 The disease in humans occurs by the transmission of Plasmodium sporozoites by a bite from an infected anopheline.
The pathway sporozoites take is via salivary glands of the mosquito through bloodstream of the host to the liver and attack the hepatocytes. There occurs a 1000-fold division till the formation of mature schizonts having thousands of daughter merozoites. 81 One of the causes of the morbidity and mortality of malaria is anemia and occurs after the massive erythrocytes lysis due to elevate parasitemia or immune haemolysis.
Malaria Diagnosis
For an effective disease management prompt and efficient diagnosis is essential. The very common symptoms of malaria include fever, body aches, nausea and vomiting, which are also seen in other common diseases. Thus laboratory examinations of the peripheral blood by microscopy, antigen detection and polymerase chain reaction (PCR) is the accurate test to confirm malaria. Light microscopy is one of the gold standards used for detection of malarial infection. This technique is accompanied by the quantification of the density of the parasite infection.
The present focus is on the betterment of the techniques used for the diagnosis, 
Therapeutics for Malaria
Literature reveals that the nanoparticles are being explored for drug delivery of antimalarial drugs which include pheroids, 84 temperature, and ionic strength was also revealed (Fig. 4) . The gel matrix could encapsulate and release bioactive molecules in a sustained manner. The developed hydrogel showed no cytotoxicity to the HeLa and L929 cell lines in culture. These type of synthesis confirmed that on modulation of the functionality and synthesis procedures the hydrogels can be designed to entrap all the structurally different drug molecule and suggest that the entrapment process is mostly physical and unrelated to the chemical nature. Simple Microscopy is the gold standard for malaria diagnosis but in local health centers with restricted resources, malaria is diagnosed presumptively in patients with fever. 100 Other new technologies include Immunochromatographic rapid diagnostic tests (RDTs) that provide an alternative to microscopy at the point of care though carries certain limitation like decreased sensitivity at lower levels of Parasitaemia inhibition at high levels of parasitaemia (prozone effect), inability to quantitate or distinguish malaria species in mixed infections, and failure to detect parasites with mutations in the genes encoding certain target antigens. [101] [102] [103] Thus the need to improvise the RDT performance, the diagnostics based on nucleic acid, PCR and isothermal amplification provide superior sensitivity. 104, 105 Hydrogels were recently explored as disposable plastic chip (Fig. 5) having a desiccated hydrogel with all the required reagents for Plasmodium specific PCR. These chip have numerous advantages like low-cost, room temperature storage and can be used on demand by rehydrating gels with unprocessed blood, moreover its performance exceeds the sensitivity by ten to fifty-fold from currently available diagnostics.
This gel based chips were capable of detecting all the plasmodium species with a limit of detection for the plasmodium falciparum of 2 parasites/µL of blood. Thus this study contributes to the front-line malaria diagnosis, eradication programs and other preclinical trials. Thus it is predicted that hydrogels are novel candidate to be used in molecular diagnostics platform in developing countries. 
Hydrogels for Tuberculosis
Tuberculosis Pathogenesis
Of all the numerous prevalent forms of diseases Tuberculosis (TB) is one of the extreme vibrant cause of morbidity and mortality. It is one of the highly infectious diseases and known to be primarily spread by inhalation of aerosol droplets expelled by infected hosts.
The first stage of tuberculosis occurs till 3 to 8 weeks and the aerosols get implanted in alveoli, the bacteria are disseminated by the lymphatic circulation to regional lymph nodes in the lung forming primary or Ghon complex. 107 The beginning of the second stage is of at least 3 months and is characterized by the hematogenous circulation of bacteria to lungs and other organs. This stage is accompanied by the fatal diseases like tuberculosis meningitis or miliary tuberculosis. The third stage occurs for 3 to 7 months and can be delayed to 2 years followed by acute pain in chest and inflammation of the pleural surfaces. give rise to patient non-compliance, decrease the attempts for a successful treatment and give rise to drug resistant strains. 108 It is well known fact that the use of these traditional anti TB drugs the M. tuberculosis achieve a non-replicating state in the host. Especially RIF, INH and ETB (excluding PZA) required the bacterial replication for their action and it is predicted that the non-replicating state is believed to reduce M. tuberculosis phenotypically resistant to other bactericidal antibiotics. 110, 111 The introduction of drug resistance phenomena was followed up by the introduction of streptomycin for curing TB by Selman Waksman. Now the call for the worry is the emergence of the extensively drug resistant strain (XDR). The M.
tuberculosis strains that are resistant to at least one of the second-line, injectable drug like capreomycin, kanamycin and to any fluoroquinolone drugs like ciprofloxacin, levofloxacin, moxifloxacin or ofloxacin). Owing to their high cost, toxicity and low efficacy high dosage is suggested as well as for a longer time interval i.e., 24 months. Moreover the use of second line anti tubular drugs also provide improved spectrum of antibiotics. Still we can say that there is a strong demand to develop such DDS using the current anti-tuberculosis drugs for their effective delivery. Nanomedicine is on impulse of developing delivery vehicles for more effective and improved treatments for TB. Here we provide the current overview of the development in nanomedicine for TB highlighting the use of hydrogels based DDS. Recent trends suggest that Intravenous (IV) administration of microparticles (MPs) which have dimensions larger than the diameter of a capillary poses a great potential for passive drug targeting to the pulmonary circulation. 115 It is known that the capillary beds of organs such as the lung, act as mechanical filters that competently entrap MPs following IV administration. 116 The necessity to traverse the mucus/ surfactant and cell/ mucosal layers encountered from the ventilation gives the opportunity for the passive lung targeting by IV administration. In addition to the cell/mucosal barrier, it is well known that mucus represents a significant diffusional barrier to micron-sized particles.
Many reports on the bio distribution and use in the pulmonary delivery on the injected particles of chitosan, 117 Polyethylene glycol (PEG) 118 , poly (lactic-co-glycolic acid) (PLGA), 119, 120 polystyrene, 121 albumin and macroaggregated albumin (MAA). 122 One of the important study by Deshmukh et al. 123 demonstrated the use a new stabilized stabilized aggregated nanogel particle (SANP) drug delivery system for targeting the lung. Biodistribution studies in male Sprague-Dawley rats were carried out with help of ex vivo imaging by covalently labeling with HiLyte Fluor™ 750 (DYE-SANPs).
Figure 7.
Bio-distribution of DYE-SANPs following IV administration. Rats (n=3) were administered DYE-SANPs (30 µm) through a tail vein catheter. Animals were euthanized by intraperitoneal injection of pentobarbital (250 mg/kg), 0.5, 6, 18, 24, and 48 h later. The heart, lung, liver, spleen, and kidneys were removed and imaged intact using the IVIS®100 imaging system. Reprinted from Reference 123 Copyright (2012), with permission from Elsevier. .
It was observed that the free dye was frequently eliminated by renal filtration, whereas DYE-SNAP was accumulated inside the lung within 30 mins and was retained for 18 hours. The fluorescent signal was seen in the course of the study in 48 hour in kidney and was not observed in lungs at that point of time. Non toxicity was also evaluated by histopathological studies using H & E staining and broncho alveolar lavage (BAL) (Fig. 7) .
These investigations suggested that the nanogels can serve as the potential alternatives for the treatment of various pulmonary diseases such as asthma, pneumonia, tuberculosis and disseminated lung cancer. 123 One of the other major known forms of the tuberculosis is the infection to the colon, which give rise to intestinal tuberculosis. Intestinal tuberculosis is a colon infection caused by MTB that is usually treated just like the pulmonary form of the disease. 124 The restriction posed by the recent therapeutics is the long path of antibiotics to eradicate the infection, which requires, isoniazid (INH, 300 mg) and rifampin (RMP, 600mg) taken daily for 18 to 24 months which have a likelihood that the bacteria will develop to the treatment. Though various side effects are associated with both the drugs like effects of INH (rash, abnormal liver function tests, hepatitis, side roblastic anemia, high anion gap metabolic acidosis, and peripheral neuropathy) and RMP (hepatitis, liver failure, breathlessness, pruritus, nausea, vomiting, and flu-like symptoms) these side effects pushes the patient to discontinue the treatment and thus develop acquired drug-resistant TB during the course of therapy 125, 126 This drug-resistant TB is more severe public health issue in many developing countries due to the high cost of treatment and more medication requirements for a longer time interval. Nano medicine emerged with nanocarriers having characteristics to increase the patient compliance with very less side effects. These nano carriers have increased effects and the drugs can be entrapped into it for the sustained delivery. 127, 128 One of the recent study by Chen et al 129 
Hydrogels for Influenza
Influenza Pathogenesis
Influenza A viruses have its place in the family Orthomyxoviridae and own 8 negative-sense RNA segments encrypting 11 known proteins. Out of these the 2 viral surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), form the root of the various serologically dissimilar virus subtypes. 130 Moreover the new subtypes have also been identified as 16 HA and 9 NA subtypes in wild water birds, which is considered as the natural host as well as the reservoir for the emergence of the all influenza A viruses. This is the major cause to infect the domestic poultry and mammals 
Diagnosis of Influenza
The emphasis for the betterment to limit the spread and an early diagnosis for a prompt laboratory test for the diagnosis of H5N1 infection was made by (MacKay et al., 2008) 132 .
Many research groups had constantly worked on the new laboratory methods for influenza detection, which included the virus detection by conventional virus culture monitored by the serological differentiation 133, 134 and also by the use of RT-PCR 135, 136 . Though these methods own limitations such as their high cost and efficient biosafety facilities. Efforts are made to replace the long-time taking methods like ELISA which is time consuming as well as rapid influenza antigen test 137, 138 by the QCM biosensor based technology detection.
139-141
The use of aptamers in diagnostics have also been highlighted in comparison to antibodies due to their ability to get chemically modified and easy labelling and stability. Basically aptamers are generally known to be artificial nucleic acid ligands used for specifically targeting against certain targets, such as amino acids, drugs and other bioactives. 142 Herein, we discuss the use of hydrogels for sensitive detection of the AIV H5N1. Moreover the use of DNA and aptamer based hydrogel systems for the biosensing applications have been highlighted. 143 The characteristic properties of DNA of folding into unique secondary and tertiary structures and its inherent biocompatibility and easy synthesis make it a perfect candidate to engineer hydrogel based systems for application in nanomedicine and biosensing. 144, 145 Hydrogel have the superiority to preserve the biological activity of the sensing material as well as diversity of substrates embedded within the hydrogel matrix.
Owing to the high loading capability, relatively small amount of hydrogel could be employed and the patterning inside the surface modified microfluidic channels would provide a stable 
Therapeutics of Influenza
The operations of the influenza virus as a bioterrorism agent have prompted the recent research to develop novel vaccines and strategies to handle this pandemic. The toughest part to achieve a complete protection level against the increasing spread of the deadly virus is in the current vaccine strategies, which require more time to generate billion monovalent doses that have optimum immunization dose for 500 million individuals with that of the two doses of the killed vaccines required for the defence. The two main recognised vaccines for this deadly virus are known as killed virus vaccine given as intramuscular injection and the other is a reduced live vaccine particular as a nasal spray. Though the emerging strains of virus which expresses variant antigenic epitopes urges the need for new vaccine development.
Moreover the antigenic drift and shift causes the loss of effectiveness of the current influenza virus vaccines that show antiviral CD8+ T cell responses may evade the major drawback of the commercially available vaccines. Thus vaccines that have the capacity to generate the CD8+ T cell response s against the viral molecules and conserved among the various serotypes of influenza virus and can serve as "universal vaccines". 147 The major concern is that yet there is no such CD8+ T cell inducing vaccine against influenza virus. As these cells require replication and the protein immunization is ineffective an interesting study by the Boesteanu et al 148 developed a biopolymer encapsulated live influenza virus to vaccinate C57Bl/6J mice using a subcutaneous route of administration. The infection was induced by the exposure of the respiratory tract to virus. It is well known that from last many years' large doses of influenza virus intraperitoneally (IP) to prime animals for secondary responses [149] [150] [151] with reports of no infection. IP injection of 3×106 TCID50 PR8 influenza strain induces no inflammatory cytokines in tissues and no viral replication or weight loss in animals. 152 The use of alginate biopolymer to encapsulate the live virus was an initiative to provide an additional layer of protection by aerosols containing the live virus (Fig. 10) . This It was also demonstrated that the system enhanced the transepithelial transport via the paracellular routes due to the disorganization of ZO-1 protein in nasal epithelial tissue.
Superior antigen-specific systemic immune responses and mucosal IgA immunity without adjuvants was achieved in comparison to the naked H5N1 split antigen and MF59 adjuvant
antigen. Figure 11 demonstrate the potential of the of HTCC hydrogels using non-invasive fluorescence imaging. It was well observed that no signal source from the fluorescence labeled antigen was detected after 1 h when mice were treated with PBS/antigen. Detection of strong fluorescence intensity after 1 h once hydrogel/antigen was directed, and the residence time was for at least 2 h in the nasal cavity. It also shows the quantitative measurement of nasal fluorescence intensity and more than 54% antigen was in the nasal tissue after the codelivery with hydrogel over 2 h. In comparison, a sharp decrease was observed in PBS/ antigen group, and only 12% of antigen retained in nasal cavity. Thus this system also supported the fact that hydrogels possess an enhanced delivery effect and suggested that the HTCC hydrogels are a perfect candidate to act as an adjuvant -free vaccine delivery systems for intranasal H5N1 split antigen vaccination.
Nanomedicine for Ebola
Ebola virus earlier known as Zaire ebola virus is one of the five viruses within the genus ebolavirus. 155 The major concern for the outbreak of this deadly diseases for public health is the shortage of approved vaccines and post exposure treatment. There is partial success in the development of the therapeutics and prompt diagnostics. 156 The upsurge for the post exposure therapeutics is in demand due to the localized and sporadic nature of ebola infection. The extent of survival of the non-human primates is typically 6-9 days once infected. This poses a great challenge on the treatment for reduction in virus replication till the immune response expands for effective control of the infection (Figure 12) . Presently, the post therapeutics are to be given in an hour to completely protect the experimentally infected animals. 157, 158 The strong immunity against the adenovirus significantly hinders its development as antigen vectors. Nanomedicine is emerging as cutting edge in clinical medicine and provides a synergistic approach for design and diagnostics of NFs. The invent of mucosal vaccination over conventional intramuscular (IM) or subcutaneous immunization suggest an effective system and mucosal immune response. 159 Recently a research group showed that mucosal delivery of adenovirus-based vaccines could efficiently evade the pre-existing immunity. Ad-GPZ antigen co-delivered with QD-60 and QD-79.5 hydrogels encouraged high systemic response as well as the respiratory mucosal immune responses thus exhibiting a magnified humoral immunity. 160 Recent advancements show the use of Nanotechnology based electrochemical immunosensors based miniaturized devices which have the ability to target the analytes (pM level). Researchers suggest the use of miniaturized electrochemical ebola sensing systems for early detection of EBOV level. 161 The emphasis on the developments of hydrogel based sensors based on the dissociation and displacement of protein binding partners. In this context, the hydrogel technology can surely come up with market opportunities for personalised nanomedicine. 
Future prospective and challenges
Though the dynamic research and development worldwide have controlled the intensification of the infectious disease yet the social factors contributing to these infections such as lack of adequate human and child health care, high international travel and the demographic as well as environmental factors which include urbanization, overgrowing population, cleanliness are the major challenges that need to be considered to limit the spread of the deadly diseases in Hydrogel based nasal spray are in demand as they possess better route of drug delivery due to enhanced blood circulation and increased surface area for adsorption. 160 Moreover the stimuli responsive hydrogels based systems still remain a challenge for drug delivery as there is yet lot to explore for the simultaneous existence of pH gradient and an oxidative environment in certain pathological conditions. The interactions of the cell and genes and the hydrogels and the underlying mechanism at the nanoscale level has to be understood for a successful translation from lab to market applications in nanomedicine. As we are towards the beginning of the new millennium new NFs and diagnostic technologies would allow rapid disease cure and diagnosis and make things easier for clinicians to detect the organism causing the specific disease and existence of antimicrobial resistance genes. A long term commitment is required to fight against these infectious diseases. Prospective to exploit the nanotechnology based systems specifically hydrogels is due to their ability to transform the specificity and efficacy of the present existing drugs as well as improve their clinical applications. There is still a need to pursue the effective health infrastructures for the complete eradication of the epidemics and pandemics world-wide. These systems will act as catalyst for individual infectious diseases like malaria, slow down the spread of the deadly Ebola crisis and also the destruction triggered by the HIV/AIDS. Presently, there is an urgent need to outbreak the competences of nanotechnology and boost up the pathogen detection for deadly Ebola virus. 161 The quick detection of Ebola virus is the most important factor in lowering down the circulation rate of the virus inside the patient's body. The detectable virus level is attained in at least 3 days after the symptoms appear. Thus funding agencies like the US National
Institutes of Health (NIH) supports on the research and development for novel diagnostics for in the forms of hydrogels that have been manufactured such as particle form (nanogels), 165 inhalable form, 166 liquid injectable form (intravenous and subcutaneous), 167 as a patch for scaffolds 168 and in oral dosages form 169 make them perfect candidate to be exploited for chemotherapy and drug resistance in infectious diseases. For tuberculosis the nanotechnology based systems allows the increased transcytosis in the gut lumen's M cells which enhance the intracellular uptake in the lining epithelium, and improved uptake in the Peyer's patch. This process reduces the loss of the active anti TB chemical in the bowels prior of entering the bloodstream and radically improve the bioavailability of the drug. 170, 171 The significant features of hydrogels such as particle size and surface can be modulated to avoid the rapid clearance by the phagocytic cells and thus promotes the active and passive targeting of the drug. The design of hydrogels in the form of controlled and sustained release systems improve the therapeutic efficacy and significantly reduce the side effects of the drug. The major advantages of using hydrogel based systems of the NFs to cure infectious diseases is their ability to reach the smallest capillary vessels owing to their tiny volume, porous structure that allow them to penetrate across the tissue by paracellular and transcellular pathways. It is noteworthy that the use of biodegradable polymers like chitosan, cellulose, Polylactic acid, PLGA etc for the synthesis of hydrogels make the NFs backbone completely degradable into compatible monomers which are non -toxic. These polymers owe the feature to be functionalized and have the ability to self-assemble into well-defined particles.
Moreover, the nanogels formulations have been reported to show the efficient loading of payloads which is not achieved by the conventional nanotechnology based carriers. 172 NFs have also shown to functions as adjuvants to enhance the immunostimulatory properties of the old vaccines and can increase the immunogenicity of vaccines by activating immune inflammatory reactions which induces memory responses.
Conclusions
This review explored the salient features of hydrogels with their competence and potentials to cure infectious diseases. Owing to the tunable structural and functional characteristics of hydrogels obtained by modulating synthesis approach they find great potential as nanocarriers to achieve site-specific drug delivery and release. Recently hydrogels have proven their potentials to develop future personalized nanomedicine to cure infectious diseases. In-spite of significant proven applications of hydrogels to manage infectious diseases, significant efforts should be made to design and develop smart hydrogels in nano-domain with improved characteristics and easy processing needed to develop therapeutics against target diseases. The emphasis to develop injectable hydrogels, nasal sprays and drops should be made for patient compliance. This review is a call to increase such significant efforts to develop hydrogel based therapeutic cargos-specific to target diseases, to be tested using animal model to promote as translational medicine.
